Other
Azienda USL - IRCCS di Reggio Emilia
Total Trials
3
Recruiting
3
Active
3
Completed
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed trials have results
Key Signals
3 recruiting
Enrollment Performance
Analytics
N/A
2(100.0%)
2Total
N/A(2)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT06236373Recruiting
The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia
Role: collaborator
NCT06514131Not ApplicableRecruiting
Water Hygiene Versus Waterless Hygiene Technology for Totally Dependent Hospitalized Patients
Role: collaborator
NCT05984797Not ApplicableRecruiting
Integrated Short-Term Palliative Rehabilitation in Incurable Cancer
Role: collaborator
All 3 trials loaded